• Solutions
  • Clinical Need
  • Clinical Evidence
  • About Us
HemoCath - Engineering better solutions for people with heart failure
  • Solutions
  • Clinical Need
  • Clinical Evidence
  • About Us

Engineering better solutions for people with heart failure

HemoCath

HemoCath™ PA catheter
The HemoCath™ pulmonary artery (PA) catheter directly measures the two most important metrics (PAP, CVP) for the diagnosis and monitoring of patients with heart failure (HF).

Substantially less invasive, more accurate and easier-to-use than existing PA catheters  


Temporarily inserted into a brachial vein on the arm and positioned into the pulmonary artery 

Cloud-connected to the Luc™ HFM platform

Providing mobility and comfort to patients




Picture
Introducing Luc™
The Luc™ heart failure management (HFM) platform for optimal AI monitoring & management of HF patients in hospitals and at home  —  reducing hospital stay for heart failure  —  providing hospital cost savings.  ​
Picture

Picture
The HemoCath™ PA catheter and Luc™ HFM platform  are not currently approved for clinical use.​
© 2023 HemoCath Ltd. All rights reserved. HemoCath and HemoCath logo are trademarks of HemoCath Ltd.​
  • Solutions
  • Clinical Need
  • Clinical Evidence
  • About Us